These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25326929)

  • 1. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings.
    Fagerness J; Fonseca E; Hess GP; Scott R; Gardner KR; Koffler M; Fava M; Perlis R; Brennan FX; Lombard J
    Am J Manag Care; 2014 May; 20(5):e146-56. PubMed ID: 25326929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?
    Herbild L; Bech M; Gyrd-Hansen D; Christensen M; Werge T; Nielsen KA
    Scand J Public Health; 2011 Mar; 39(2):147-55. PubMed ID: 21257648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
    Winner JG; Carhart JM; Altar CA; Goldfarb S; Allen JD; Lavezzari G; Parsons KK; Marshak AG; Garavaglia S; Dechairo BM
    Curr Med Res Opin; 2015; 31(9):1633-43. PubMed ID: 26086890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.
    Brown LC; Lorenz RA; Li J; Dechairo BM
    Clin Ther; 2017 Mar; 39(3):592-602.e1. PubMed ID: 28238356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
    Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
    Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of combinatorial pharmacogenomic guidance in treating psychiatric disorders.
    Benitez J; Cool CL; Scotti DJ
    Per Med; 2018 Nov; 15(6):481-494. PubMed ID: 30256179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.
    Perlis RH; Mehta R; Edwards AM; Tiwari A; Imbens GW
    Depress Anxiety; 2018 Oct; 35(10):946-952. PubMed ID: 29734486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial.
    Olson MC; Maciel A; Gariepy JF; Cullors A; Saldivar JS; Taylor D; Centeno J; Garces JA; Vaishnavi S
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28314093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cinacalcet adherence and costs in patients on dialysis.
    Lee A; Song X; Khan I; Belozeroff V; Goodman W; Fulcher N; Diakun D
    J Med Econ; 2011; 14(6):798-804. PubMed ID: 21988567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Outcomes Following Combinatorial Pharmacogenomic Testing for Elderly Psychiatric Patients.
    Jablonski MR; Lorenz R; Li J; Dechairo BM
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):324-332. PubMed ID: 31842673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy.
    Brixner D; Biltaji E; Bress A; Unni S; Ye X; Mamiya T; Ashcraft K; Biskupiak J
    J Med Econ; 2016; 19(3):213-28. PubMed ID: 26478982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of value-based insurance design with a large retail employer.
    Kim YA; Loucks A; Yokoyama G; Lightwood J; Rascate K; Serxner SA
    Am J Manag Care; 2011 Oct; 17(10):682-90. PubMed ID: 22106461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a computerized medication shared decision making tool in community mental health settings: impact on psychotropic medication adherence.
    Stein BD; Kogan JN; Mihalyo MJ; Schuster J; Deegan PE; Sorbero MJ; Drake RE
    Community Ment Health J; 2013 Apr; 49(2):185-92. PubMed ID: 22837104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to improve medication adherence in mental health: the update of a systematic review of cost-effectiveness.
    García-Pérez L; Linertová R; Serrano-Pérez P; Trujillo-Martín M; Rodríguez-Rodríguez L; Valcárcel-Nazco C; Del Pino-Sedeño T
    Int J Psychiatry Clin Pract; 2020 Nov; 24(4):416-427. PubMed ID: 32609024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders.
    Blasco-Fontecilla H
    J Neural Transm (Vienna); 2019 Jan; 126(1):101-107. PubMed ID: 29626260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of adherence mismeasurement in serious mental illness: a claims-based analysis.
    Shafrin J; Forma F; Scherer E; Hatch A; Vytlacil E; Lakdawalla D
    Am J Manag Care; 2017 May; 23(5):e156-e163. PubMed ID: 28810130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.